- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01335776
A Comparison of MBSR and CBT for the Treatment of Insomnia in Cancer (I-CAN SLEEP)
June 17, 2013 updated by: Tavis S. Campbell, University of Calgary
An Objective Comparison of Cognitive Behavioral Therapy and Mindfulness-based Stress Reduction for the Treatment of Insomnia in Cancer Survivors Using Wrist Actigraphy: A Randomized Noninferiority Trial
Sleep disturbance in cancer patients is often overlooked despite its documented high prevalence and negative impact.
There are few empirically validated non-pharmacological treatments for insomnia and many patients are unwilling to rely on sleeping medications.
This study will determine whether Mindfulness-Based Stress Reduction (a program that teaches meditation and yoga) produces equivalent results with the additional benefits of reduced stress and mood disturbance, to an already established treatment for insomnia, Cognitive-Behavioral Therapy.
This will allow for the expansion of treatment options for insomnia beyond what is currently available and improve quality of life for millions of cancer survivors.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
111
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2S 3C1
- Tom Baker Cancer Centre-Holy Cross Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- English speaking
- Non metastatic cancer
- 1 month post chemotherapy/radiation treatment (hormone treatment okay)
- Diagnosis of Primary or Secondary Insomnia
Exclusion Criteria:
- Presence of another sleep disorder
- Presence of another Axis I diagnosis (not in remission)
- Inability to attend at least 5 out of the 8 treatment sessions
- Randomization Refusal
- Previous participation in CBT-I or MBSR
- Shift work
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Behavior Therapy
Cognitive Behavior Therapy for insomnia consists of stimulus control therapy, sleep restriction therapy, cognitive therapy and relaxation.
|
This treatment is delivered to small groups over the course of 8 weekly, 90 minute sessions
Other Names:
|
|
Experimental: Mindfulness-Based Stress Reduction
The program consists of three primary components: theoretical material related to relaxation, meditation, and the mind-body connection; experiential practice of meditation and yoga and home based practice; group process focused on problem solving and support.
|
This intervention is provided over the course of eight, weekly, 90 minute sessions, plus one 6 hour silent retreat.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Insomnia Severity from baseline to 3 months
Time Frame: Baseline, Post-Treatment, 3 month follow up
|
Baseline, Post-Treatment, 3 month follow up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in objective measures of sleep using Wrist Actigraphy from baseline to 3 months
Time Frame: Baseline, Post Treatment, 3 month follow up
|
Baseline, Post Treatment, 3 month follow up
|
|
Change in subjective measures of sleep using Sleep Diaries from baseline to 3 months
Time Frame: Baseline (one week), During treatment (7 weeks), Post Treatment (1 week), 3 month Follow up (1 week)
|
Baseline (one week), During treatment (7 weeks), Post Treatment (1 week), 3 month Follow up (1 week)
|
|
Change in Pittsburgh Sleep Quality Index scores from baseline to 3 months
Time Frame: Baseline, Post Treatment, 3 month follow up
|
Baseline, Post Treatment, 3 month follow up
|
|
Change in Dysfunctional Attitudes and Beliefs about Sleep Scale scores from baseline to 3 months
Time Frame: Baseline, Post Treatment, 3 month folllow up
|
Baseline, Post Treatment, 3 month folllow up
|
|
Change in Calgary Symptoms of Stress Inventory scores from baseline to 3 months
Time Frame: Baseline, Post Treatment, 3 month folllow up
|
Baseline, Post Treatment, 3 month folllow up
|
|
Change in Five Facet Mindfulness Questionnaire scores from baseline to 3 months
Time Frame: Baseline, Post Treatment, 3 month folllow up
|
Baseline, Post Treatment, 3 month folllow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
April 12, 2011
First Submitted That Met QC Criteria
April 13, 2011
First Posted (Estimate)
April 14, 2011
Study Record Updates
Last Update Posted (Estimate)
June 19, 2013
Last Update Submitted That Met QC Criteria
June 17, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RT735639
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
Clinical Trials on Cognitive Behavior Therapy
-
Laval UniversityUniversity of California, BerkeleyCompleted
-
Center for Psychological ConsultationCompletedObsessive Compulsive DisorderUnited States
-
Stockholm UniversityKarolinska InstitutetCompleted
-
VA Office of Research and DevelopmentCompleted
-
Baylor College of MedicineSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedDepression | AnxietyUnited States
-
University of OsloNot yet recruitingCognitive Behavior Therapy | Depression - Major Depressive Disorder | Psychodynamic TherapyNorway
-
Ohio State University Comprehensive Cancer CenterCompletedMajor Depressive DisorderUnited States
-
Henry M. Jackson Foundation for the Advancement...National Alliance for Research on Schizophrenia and DepressionCompletedSuicide, AttemptedUnited States
-
Shanghai 10th People's HospitalRecruitingColorectal Cancer | Cognitive Behavior Therapy | Immune FunctionChina
-
Neuropsychiatrischen Zentrums Hamburg-AltonaUniversity of Hamburg-EppendorfRecruiting